CAR-T Cells Targeting Immune Checkpoint Pathway Players
CAR (Chimeric antigen receptor)-T cell therapy has become a very promising type of immunotherapy against hematological cancers. This report is focused on CAR-T cells targeting immune checkpoint proteins expressed on tumor cells. The CD70, CD47, CD80, CD86, B7H3, B7H4, PDL-1, TIGIT CAR-T cells and ot...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-04-01
|
| Series: | Frontiers in Bioscience-Landmark |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/FBL/27/4/10.31083/j.fbl2704121 |